These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7557345)

  • 1. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug.
    Venkateswarlu K; Denning DW; Manning NJ; Kelly SL
    FEMS Microbiol Lett; 1995 Sep; 131(3):337-41. PubMed ID: 7557345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of mechanisms of fluconazole resistance in a Candida albicans isolate from a Japanese patient with chronic mucocutaneous candidiasis.
    Kamai Y; Maebashi K; Kudoh M; Makimura K; Naka W; Uchida K; Yamaguchi H
    Microbiol Immunol; 2004; 48(12):937-43. PubMed ID: 15611610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains.
    Franz R; Kelly SL; Lamb DC; Kelly DE; Ruhnke M; Morschhäuser J
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3065-72. PubMed ID: 9835492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluconazole-resistant Candida albicans.
    Boken DJ; Swindells S; Rinaldi MG
    Clin Infect Dis; 1993 Dec; 17(6):1018-21. PubMed ID: 8110924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains.
    Löffler J; Einsele H; Hebart H; Schumacher U; Hrastnik C; Daum G
    FEMS Microbiol Lett; 2000 Apr; 185(1):59-63. PubMed ID: 10731607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation of intracellular structure corresponding to reduced affinity of fluconazole for cytochrome P-450 in two low-susceptibility strains of Candida albicans isolated from a Japanese AIDS patient.
    Maebashi K; Kudoh M; Nishiyama Y; Makimura K; Kamai Y; Uchida K; Yamaguchi H
    Microbiol Immunol; 2003; 47(2):117-24. PubMed ID: 12680714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple amino acid substitutions in lanosterol 14alpha-demethylase contribute to azole resistance in Candida albicans.
    Favre B; Didmon M; Ryder NS
    Microbiology (Reading); 1999 Oct; 145 ( Pt 10)():2715-25. PubMed ID: 10537193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y132H substitution in Candida albicans sterol 14alpha-demethylase confers fluconazole resistance by preventing binding to haem.
    Kelly SL; Lamb DC; Kelly DE
    FEMS Microbiol Lett; 1999 Nov; 180(2):171-5. PubMed ID: 10556708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
    Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of fluconazole resistance in Candida krusei.
    Orozco AS; Higginbotham LM; Hitchcock CA; Parkinson T; Falconer D; Ibrahim AS; Ghannoum MA; Filler SG
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2645-9. PubMed ID: 9756770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363.
    Lamb DC; Kelly DE; Manning NJ; Kelly SL
    FEMS Microbiol Lett; 1997 Feb; 147(2):189-93. PubMed ID: 9119192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G464S amino acid substitution in Candida albicans sterol 14alpha-demethylase causes fluconazole resistance in the clinic through reduced affinity.
    Kelly SL; Lamb DC; Loeffler J; Einsele H; Kelly DE
    Biochem Biophys Res Commun; 1999 Aug; 262(1):174-9. PubMed ID: 10448088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.
    Ruhnke M; Adler A; Müller FM
    Clin Microbiol Infect; 2000 Apr; 6(4):220-3. PubMed ID: 11168112
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model.
    Reynes J; Mallie M; Ravisse P; Bastide JM
    J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
    White TC
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1482-7. PubMed ID: 9210670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients.
    Lamb DC; Corran A; Baldwin BC; Kwon-Chung J; Kelly SL
    FEBS Lett; 1995 Jul; 368(2):326-30. PubMed ID: 7628631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism of fluconazole resistance associated with fluconazole sequestration in Candida albicans isolates from a myelofibrosis patient.
    Maebashi K; Kudoh M; Nishiyama Y; Makimura K; Uchida K; Mori T; Yamaguchi H
    Microbiol Immunol; 2002; 46(5):317-26. PubMed ID: 12139391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
    Hu Y; Hu Y; Lu Y; Huang S; Liu K; Han X; Mao Z; Wu Z; Zhou X
    Mycopathologia; 2017 Apr; 182(3-4):397-402. PubMed ID: 27659805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation.
    Kelly SL; Lamb DC; Kelly DE; Manning NJ; Loeffler J; Hebart H; Schumacher U; Einsele H
    FEBS Lett; 1997 Jan; 400(1):80-2. PubMed ID: 9000517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antifungal agents which inhibit lanosterol 14alpha-demethylase in Candida albicans CCH442.
    Zakula D; Capobianco JO; Goldman RC
    J Antimicrob Chemother; 1997 Feb; 39(2):261-4. PubMed ID: 9069550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.